Showing 1 - 3 results of 3 for search 'William L Redmond', query time: 0.01s Refine Results
  1. 1
    Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy

    Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy by Kengo Tanigawa, William L. Redmond

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering

    INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering by William L Redmond, Yoshinobu Koguchi, Melissa J Kasiewicz, Annah S Rolig, Nisha Holay, Bryan Becklund, Anya Polovina, Sae Jeong Ahn, Brendan P Eckelman, Rashi Yadav, Thi Staebler, Noah D Simons, Yaiza Diaz de Durana

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy

    SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy by Evan J Lipson, Charlie Garnett-Benson, William L Redmond, Robert L Ferris, Marco Ruella, Mark Yarchoan, Kurt A Schalper, Daniela S Thommen, Marleen Kok, Ryan J Sullivan, Harriet M Kluger, Luca Paruzzo, Russell W Jenkins, Anthony R Cillo, Keith Tolley

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: